The Prescription Drug Marketing Act sets the compliance framework for pharmaceutical sample programs. For companies managing samples at scale — across field forces, digital portals, and fulfillment centers — understanding PDMA requirements is not optional. It is the foundation of every compliant sampling program.
Pharmaceutical product sampling is one of the most effective tools in a brand team’s commercial toolkit. Getting a medication into a physician’s hands — creating direct product experience at the point of prescribing — drives awareness and trial in ways that other promotional activities simply cannot replicate. But sample programs come with a significant and non-negotiable compliance obligation, governed primarily by the Prescription Drug Marketing Act of 1987 (PDMA) and its implementing regulations.
For pharma companies managing samples at scale — hundreds of thousands of units distributed across thousands of healthcare providers — PDMA compliance is a continuous operational discipline, not a one-time setup task.
What PDMA requires
The Prescription Drug Marketing Act was enacted to prevent the diversion and counterfeiting of prescription drugs, and sampling is one of its central areas of regulation. The key PDMA requirements for sample programs include:
Written requests and signatures
Samples may only be provided to licensed practitioners upon a written request that includes the practitioner’s signature, address, and professional designation. This request must be made before or at the time of delivery. Digital and electronic signature systems that meet regulatory requirements have made this process more efficient, but the requirement itself remains firm.
Sample accountability records
Manufacturers must maintain complete records of all samples distributed: what was distributed, to whom, when, and in what quantity. These records must be made available to the FDA upon request. Gaps in accountability records are a primary source of PDMA violations and regulatory exposure.
Reconciliation and inventory management
Sample inventories must be periodically reconciled — matching what was distributed against requests and signatures. Field representative audits, typically conducted annually, verify that samples in a rep’s possession are properly accounted for and stored. Closeout procedures when a rep leaves the field must ensure all remaining samples are properly returned, destroyed, or transferred.
Storage and handling
Samples must be stored under conditions appropriate for the drug — including temperature-controlled storage for products that require it. Chain of custody documentation must be maintained throughout the distribution process.
Where compliance programs break down
PDMA violations typically cluster around a few recurring failure points:
- Incomplete or unsigned request forms
- Sample quantities distributed without corresponding requests
- Field rep inventories that cannot be reconciled at audit
- Inadequate storage and handling documentation
- Closeout failures when reps transition out of a territory
Each of these failure points represents both regulatory risk and brand risk. An FDA audit that surfaces PDMA deficiencies can result in warning letters, consent decrees, and significant reputational damage.
The role of technology in PDMA compliance
Modern sample management platforms have made PDMA compliance substantially more achievable — replacing paper-based processes with digital audit trails, automating signature capture, and providing real-time visibility into sample inventory and distribution status.
Key technology capabilities that support PDMA compliance include:
- Electronic sample request and signature capture (eSampling portals)
- Real-time inventory tracking with automated reconciliation
- Field rep audit tools that document inventory status and closeout procedures
- Centralized reporting that aggregates distribution data across all channels
- Alerts for anomalies — unusual distribution patterns, signature discrepancies, or reconciliation gaps
CareTria’s approach to PDMA-compliant sampling
CareTria has built its sample management business — operating under Knipper Health with 40 years of experience — around the principle that compliance is not an add-on to sampling operations. It is embedded in every process, every system, and every workflow.
MySampleCloset, CareTria’s eSampling portal, provides licensed healthcare practitioners with a compliant digital channel for requesting samples — with electronic signature capture, real-time fulfillment tracking, and automated accountability reporting built in. Field representative audits and closeout services ensure that the field-side of sample accountability is managed with the same rigor as the fulfillment side.
The result is a sample program that can scale to high volume — serving national field forces and large HCP networks — without sacrificing the compliance controls that protect brand and regulatory standing.
➤ CareTria Sample Accountability →
➤ MySampleCloset eSampling Portal →
Running a sample program with fragmented accountability systems? CareTria’s end-to-end sample management platform handles PDMA compliance from request to closeout.
